Jagsonpal Pharmaceuticals Ltd
JAGSNPHARM
Company Profile
Business description
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others.
Contact
3rd Floor, Phase – IV, Udyog Vihar
Plot No. 412-415, Nimai Tower
GurugramHR122015
INDT: +91 1244406710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,025
Stocks News & Analysis
stocks
Is this the $80 billion elephant Warren Buffett has been waiting for?
Morningstar’s Greg Warren says Berkshire may have little choice but to take a hard look at this huge potential acquisition.
stocks
Tesla: Board announces new pay package for CEO Elon Musk
A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,021.70 | 99.70 | 1.12% |
| CAC 40 | 7,632.01 | 85.85 | 1.14% |
| DAX 40 | 23,757.69 | 331.72 | 1.42% |
| Dow JONES (US) | 44,173.64 | 585.06 | 1.34% |
| FTSE 100 | 9,128.30 | 59.72 | 0.66% |
| HKSE | 24,774.51 | 41.06 | 0.17% |
| NASDAQ | 21,053.58 | 403.45 | 1.95% |
| Nikkei 225 | 40,607.38 | 316.68 | 0.79% |
| NZX 50 Index | 12,838.27 | 154.23 | 1.22% |
| S&P 500 | 6,329.94 | 91.93 | 1.47% |
| S&P/ASX 200 | 8,763.10 | 99.40 | 1.15% |
| SSE Composite Index | 3,602.13 | 18.82 | 0.53% |